Traversi E, Riccardi A, Montecucco C, Mazzini G, Giordano P
Tumori. 1985 Feb 28;71(1):69-74. doi: 10.1177/030089168507100113.
The proliferative activity of bone marrow blasts was determined in 19 patients with acute leukemia during early induction therapy using in vitro tritiated thymidine (3H-TdR) cytoautoradiography and propidium iodide DNA flow cytofluorometry. Following 1-3 causes of treatment, the aliquot of bone marrow blasts in 9 patients, who later achieved remission or marrow aplasia, was reduced to a greater extent that of the remaining 10 patients who failed to respond. In the first group of patients, the 3H-TdR labeling index was increased by 259-653% over the pretreatment value, whereas it was lower than 104% of the pretreatment value in all but one unresponsive patient. Leukemic blast recruitment is conceivable. It might have facilitated remission by increasing the effectiveness of the antileukemic agents administered later.
在19例急性白血病患者早期诱导治疗期间,采用体外氚标记胸腺嘧啶核苷(3H-TdR)细胞放射自显影术和碘化丙啶DNA流式细胞荧光测定法,测定了骨髓原始细胞的增殖活性。经过1 - 3个疗程的治疗后,9例后来达到缓解或骨髓抑制的患者,其骨髓原始细胞的份额下降幅度比其余10例无反应患者更大。在第一组患者中,3H-TdR标记指数比预处理值增加了259 - 653%,而在除1例无反应患者外的所有无反应患者中,该指数均低于预处理值的104%。白血病原始细胞募集是可以想象的。它可能通过提高后续给予的抗白血病药物的有效性促进了缓解。